Literature DB >> 21705778

Fatigue and depression predict physician visits and work disability in women with primary Sjögren's syndrome: results from a cohort study.

Gisela Westhoff1, Thomas Dörner, Angela Zink.   

Abstract

OBJECTIVES: Patients with primary SS (pSS) are frequently suffering from multiple enduring disorders that raise the risk of work disability and require treatment by various health-care specialists. We aimed at determining predictors of physician visits and work disability in pSS patients.
METHODS: Physician visits within the past 6 months, employment status and sick leave were compared among 176 female pSS patients and 115 age-matched controls. Dryness, pain, fatigue and depression were assessed by rating scales of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI), the Profile of Fatigue and Discomfort (PROFAD) and Patient Health Questionnaire depression measurements (PHQ-9). Factors associated with an increased number of physician visits and inability to work were determined by multivariate logistic regression analysis.
RESULTS: Patients and controls were comparable in age and education, but differed significantly in the prevalence of depression (38.1 vs 7.9%, P < 0.001), the number of physician visits [17.0 (10.0) vs 6.5 (4.5); P < 0.001] and gainful employment (≤64 years: 52.8 vs 77.1% P < 0.001). Multivariate regression analyses revealed that depression (PHQ-9) and/or fatigue, particularly lack of stamina, but not dryness, were significantly associated with physician visits and working status in pSS patients. Patients with high ratings for the statement 'I have had difficulties to keep going, was easily worn out or lacking in energy' had a highly increased risk of not being gainfully employed (adjusted OR 4.1; 95% CI 1.5, 11.2; P < 0.001).
CONCLUSION: In pSS, lack of stamina and/or depression cause a higher level of individual and societal burden than dry eyes and mouth. Fatigue and depression deserve more recognition as treatment targets in pSS.

Entities:  

Mesh:

Year:  2011        PMID: 21705778     DOI: 10.1093/rheumatology/ker208

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  26 in total

Review 1.  Productivity Losses and Costs in the Less-Common Systemic Autoimmune Rheumatic Diseases.

Authors:  Natalie McCormick; Carlo A Marra; J Antonio Aviña-Zubieta
Journal:  Curr Rheumatol Rep       Date:  2017-10-30       Impact factor: 4.592

Review 2.  The Diagnosis and Treatment of Sjögren's Syndrome.

Authors:  Ana-Luisa Stefanski; Christian Tomiak; Uwe Pleyer; Thomas Dietrich; Gerd Rüdiger Burmester; Thomas Dörner
Journal:  Dtsch Arztebl Int       Date:  2017-05-26       Impact factor: 5.594

3.  Illness perceptions and psychological distress associated with physical health-related quality of life in primary Sjögren's syndrome compared to systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Konstantinos Kotsis; Paraskevi V Voulgari; Niki Tsifetaki; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis
Journal:  Rheumatol Int       Date:  2014-04-27       Impact factor: 2.631

Review 4.  Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research.

Authors:  Kristen Davies; Emma Dures; Wan-Fai Ng
Journal:  Nat Rev Rheumatol       Date:  2021-10-01       Impact factor: 20.543

5.  Perceptions regarding a range of work-related issues and corresponding support needs of individuals with an intractable disease.

Authors:  Kumiko Imahashi; Reiko Fukatsu; Yasoichi Nakajima; Megumi Nakamura; Tateo Ito; Mariko Horigome; Yuichiro Haruna; Tatsuya Noda; Yasuto Itoyama
Journal:  Intractable Rare Dis Res       Date:  2016-08

Review 6.  Depression and anxiety in dry eye disease: a systematic review and meta-analysis.

Authors:  K H Wan; L J Chen; A L Young
Journal:  Eye (Lond)       Date:  2016-08-12       Impact factor: 3.775

7.  Work productivity among Sjögren's Syndrome and non-Sjögren's dry eye patients: a systematic review and meta-analysis.

Authors:  Gayathri K Sivakumar; Janhavi Patel; Monali S Malvankar-Mehta; Rookaya Mather
Journal:  Eye (Lond)       Date:  2021-01-21       Impact factor: 3.775

Review 8.  A systematic review of non-pharmacological interventions for primary Sjögren's syndrome.

Authors:  Katie L Hackett; Katherine H O Deane; Victoria Strassheim; Vincent Deary; Tim Rapley; Julia L Newton; Wan-Fai Ng
Journal:  Rheumatology (Oxford)       Date:  2015-06-30       Impact factor: 7.580

9.  An increase in the cerebral infarction area during fatigue is mediated by il-6 through an induction of fibrinogen synthesis.

Authors:  Hong Lei; Jian Xu; Li-Juan Cheng; Qi Guo; An-Mei Deng; Yong-Shen Li
Journal:  Clinics (Sao Paulo)       Date:  2014-06       Impact factor: 2.365

10.  Health-related quality of life and depression among participants in the Sjögren's International Collaborative Clinical Alliance registry.

Authors:  Annie Chou; John A Gonzales; Troy E Daniels; Lindsey A Criswell; Stephen C Shiboski; Caroline H Shiboski
Journal:  RMD Open       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.